logo image
search icon
Next Generation Bioprinting Market

Next Generation Bioprinting Market Size, Share & Trends Analysis Report By Type of Technology (Extrusion-based Technology, Laser-based Technology, Inkjet-based Technology, Others), By Application (Biomedical Applications, Other Applications), By End-user, Region And Segment Forecasts, 2024-2031

Report ID : 1941 | Published : 2024-05-17 | Pages: 180 | Format: PDF/EXCEL

The Next Generation Bioprinting Market Size is valued projected to record a 29.82 % CAGR during the forecast period for 2024-2031.

Key Industry Insights & Findings from the Report:

  • The next-generation bioprinting industry is being driven by a convergence of factors that represent both technological developments and rising demand for innovative healthcare and biotech solutions.
  • The increasing incidence of chronic diseases, rising R&D investment, and technological advancement are other vitally impacting attributes, likely to boost the market growth.
  • Asia Pacific dominated the market and accounted for a largest revenue share of global revenue in 2023.
  • One of the significant concerns restraining industry growth is the high research and development costs associated with bioprinting technology.

bioprinting

Next generation bioprinting also referred as 4D bioprinting, means adding a fourth dimension to these structures so that they can change their shape over time. The fourth dimension of bioprinting technology is made possible by the use of "smart materials," which change when they are exposed to certain stimuli (such as, heat, water, light, electricity, magnetic energy, stress, strain, and pressure). Structures made with next-generation bioprinting can change shape, but they can also fix themselves and adapt to changes in their environment.

This also includes printing the materials that respond to stimuli and making them work better with bio-inks. Deformed structures made with 4D printing are also hard to put together and fold. 4D bioprinting is getting a lot of attention from both academics and businesspeople. In fact, the amount of related scientific literature has grown by about 130% in the last five years, which shows how popular 4D bioprinting is becoming.

The biomedical industry has greatly benefited from the development of 4D bioprinting or next generation bioprinting technology, particularly in the areas of dentistry, scaffolds, and tissue engineering (TE). This stimulates the market and aids in its expansion overall. Any organ or tissue regeneration that occurs accidentally needs to be replaced. In the end, these factors encourage scientists to consider developing artificial tissues and organs that utilise living cells.

These circumstances will drive the market with research and advancements in bioprinting technology, which is based on bioprinters that can replicate stem cells and organs exactly. Additionally, the market share will increase in the upcoming years due to an increase in start-ups, the expanding use of 4D bioprinting for applications including tissue engineering, regenerative medicine, and medicinal applications, as well as an increase in stakeholder interest in technical breakthroughs.

However, expensive development costs, stringent regulatory restrictions for implantable devices and smart materials used in the product, as well as low awareness in low- and middle-income nations, are some of the reasons impeding market growth.

Competitive Landscape:

Some of The Key Players in The Next Generation Bioprinting Market:

  • DirectSync Surgical
  • Poietis
  • Regenhu
  • 3D Systems, Inc.
  • GeSiM
  • Stratasys
  • ROKIT Healthcare
  • Sculpteo
  • Smart3D
  • VIVAX BIO
  • EnvisionTec
  • EOS GmbH Electro Optical System
  • Materialise NV
  • Dassault Systèmes
  • Organovo Holdings, Inc.
  • CellLink
  • Izumi International, Inc
  • Advanced Solutions Life Sciences. LLC. 

Market Segmentation:

The next generation bioprinting market is segmented into three main categories Type of Technology, Application Area and End-User. By the type of technology, it comprises Extrusion-based Technology, Laser-based Technology, Inkjet-based Technology and Others. The application area includes Biomedical Applications and Others. The third segment End-User has Pharmaceutical and Biotechnology Companies, Academic Research and Development and Other End-users.

The Asia Pacific region will probably dominate the global next generation bioprinting market. Asia Pacific's primary dominant factors are new innovations and research, cooperation for development, and big investments in the region. 

Recent Developments:

  • In February 2023, 3D Systems launched its Regenerative Tissue Program with the goal of offering a superior remedy for reconstructive surgery treatments. This program was started by 3D Systems because of the noteworthy advancements made in the creation of next-generation bioprinting techniques for 3D-printed solid organs. The company is creating vascularized, patient-specific living human tissues by combining bioprinting technology, biocompatible 3D printing materials, and patient-derived cells.
  • In Oct 2022, Poietis initiated a three-year partnership to create a clinical-grade cardiac patch with functionalized properties using Poietis' bioprinting technology. The objective of this partnership was to establish the animal model and assess the effectiveness of a bioprinted biomaterial on an in vivo heart failure model. The objective was to reach the stage of clinical trials within a timeframe of three to four years, subsequent to an initial phase of demonstrating the feasibility of the concept.

The Next Generation Bioprinting Market Report Scope:

Report Attribute

Specifications

Growth Rate CAGR

CAGR of 29.82 % from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Billion and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Type of Technology, By Application, By End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

DirectSync Surgical, Poietis, 3D Systems, Inc., GeSiM, Regenhu, ROKIT Healthcare, Sculpteo, Smart3D, Stratasys, VIVAX BIO, EnvisionTec, EOS GmbH Electro Optical System, Materialise NV, Dassault Systèmes, Organovo Holdings, Inc., CellLink, Izumi International, Inc, Advanced Solutions Life Sciences. LLC and other market players.

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Next Generation Bioprinting Market Snapshot

Chapter 4. Global Next Generation Bioprinting Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis

Chapter 5. Market Segmentation 1: By Type Estimates & Trend Analysis
5.1. By Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Type:

5.2.1. Extrusion-based Technology
5.2.2. Laser-based Technology
5.2.3. Inkjet-based Technology
5.2.4. Others

Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Type & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Application:

6.2.1. Biomedical Applications
6.2.2. Other Application

Chapter 7. Market Segmentation 3: By End User Estimates & Trend Analysis
7.1. By Type & Market Share, 2019-2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End User:

7.2.1. Pharmaceutical and Biotechnology Companies
7.2.2. Academic Research and Development
7.2.3. Other End-users

Chapter 8. Next Generation Bioprinting Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Type, 2024-2031
8.1.2. North America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.1.3. North America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
8.1.4. North America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts by country, 2024-2031

8.1.5. U.S.
8.1.6. Canada
8.2. Europe

8.2.1. Europe Next Generation Bioprinting Market revenue (US$ Million) By Type, 2024-2031
8.2.2. Europe Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.2.3. Europe Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By End User 2024-2031
8.2.4. Europe Next Generation Bioprinting Market revenue (US$ Million) by country, 2024-2031

8.2.5. Germany
8.2.6. Poland
8.2.7. France
8.2.8. Italy
8.2.9. Spain
8.2.10. UK
8.2.11. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Next Generation Bioprinting Market revenue (US$ Million) By Type, 2024-2031
8.3.2. Asia Pacific Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.3.3. Asia Pacific Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
8.3.4. Asia Pacific Next Generation Bioprinting Market revenue (US$ Million) by country, 2024-2031

8.3.5. China
8.3.6. India
8.3.7. Japan
8.3.8. Australia
8.3.9. Rest of Asia Pacific


8.4. Latin America

8.4.1. Latin America Next Generation Bioprinting Market revenue (US$ Million) By Type, 2024-2031
8.4.2. Latin America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.4.3. Latin America Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
8.4.4. Latin America Next Generation Bioprinting Market revenue (US$ Million) by country, (US$ Million) 2024-2031

8.4.5. Brazil
8.4.6. Rest of Latin America

8.5. Middle East & Africa

8.5.1. Middle East & Africa Next Generation Bioprinting Market revenue (US$ Million) By Type, (US$ Million) 2024-2031
8.5.2. Middle East & Africa Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By Application, 2024-2031
8.5.3. Middle East & Africa Next Generation Bioprinting Market revenue (US$ Million) estimates and forecasts By End User, 2024-2031
8.5.4. Middle East & Africa Next Generation Bioprinting Market revenue (US$ Million) by country, (US$ Million) 2024-2031

8.5.5. South Africa
8.5.6. GCC Countries
8.5.7. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles
9.2.1. DirectSync Surgical
9.2.2. Poietis
9.2.3. Regenhu
9.2.4. 3D Systems, Inc.
9.2.5. GeSiM
9.2.6. Stratasys
9.2.7. ROKIT Healthcare
9.2.8. Sculpteo
9.2.9. Smart3D
9.2.10. VIVAX BIO
9.2.11. EnvisionTec
9.2.12. EOS GmbH Electro Optical System
9.2.13. Materialise NV
9.2.14. Dassault Systèmes
9.2.15. Organovo Holdings, Inc.
9.2.16. CellLink
9.2.17. Izumi International, Inc
9.2.18. Advanced Solutions Life Sciences. LLC

Next Generation Bioprinting Market Segments:

Global Next Generation Bioprinting Market, by Type of Technology

  • Extrusion-based Technology
  • Laser-based Technology
  • Inkjet-based Technology
  • Others

Bioprinting

Global Next Generation Bioprinting Market, by Application

  • Biomedical Applications
  • Other Applications

Global Next Generation Bioprinting Market, by End-User

  • Pharmaceutical and Biotechnology Companies,
  • Academic Research and Development
  • Other End-users

Global Next Generation Bioprinting Market, by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Next Generation Bioprinting Market, by Country

  • U.S.
  • Canada

Europe Next Generation Bioprinting Market, by Country

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Next Generation Bioprinting Market, by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Next Generation Bioprinting Market, by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Next Generation Bioprinting Market, by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

 InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

What is the Next Generation Bioprinting Market Growth?

DirectSync Surgical, Poietis, 3D Systems, Inc., GeSiM, Regenhu, ROKIT Healthcare, Sculpteo, Smart3D, Stratasys, VIVAX BIO, EnvisionTec, EOS GmbH Elect

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Biotechnology

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach